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Background: Wound healing is a complex biologic process that involves the integration of inflammation, mitosis,
angiogenesis, synthesis, and remodeling of the extracellular matrix. However, some wounds fail to heal properly
and become chronic. Although some simulated chronic wound models have been established, an efficient
approach to treat chronic wounds in animal models has not been determined. The aim of this study was to
develop a modified rat model simulating the chronic wounds caused by clinical radiation ulcers and examine the
treatment of chronic wounds with adipose-derived stem cells.
Results: Sprague–Dawley rats were irradiated with an electron beam, and wounds were created. The rats received
treatment with adipose-derived stem cells (ASCs), and a wound-healing assay was performed. The wound sizes
after ASC treatment for 3 weeks were significantly smaller compared with the control condition (p < 0.01).
Histological observations of the wound edge and immunoblot analysis of the re-epithelialization region both
indicated that the treatment with ASCs was associated with the development of new blood vessels. Cell-tracking
experiments showed that ASCs were colocalized with endothelial cell markers in ulcerated tissues.
Conclusions: We established a modified rat model of radiation-induced wounds and demonstrated that ASCs
accelerate wound-healing.
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Approximately 50% of cancer patients receive radiation
as an adjuvant therapy [1]. Although radiation therapy
technology has progressed substantially, patients still
suffer from various degrees of non-specific radiation da-
mage to non-cancerous tissues [2]. Radiation ulcers have
posed a formidable challenge to reconstructive surgeons
[3,4]; they cause great distress to patients, impair their
quality of life, and require enormous medical resources.* Correspondence: shyigen@ms26.hinet.net; jchan9473@gmail.com;
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reproduction in any medium, provided the orThese chronic wounds can last for several years, and
some may even lead to amputation [5].
The mechanism of radiation injury is through damage
to the DNA of cells, leading to cell apoptosis or necrosis.
The histological features are vascular dilation and throm-
bosis, inflammation, and finally, hypovascular and fibrosis
abscent of the epithelium and hair follicles. Radiation in-
jury may cause redness, peeling, moist ulcers and other
features depending on the severity. Ulcers may take se-
veral months to several years to heal [1].
Strategies for treating chronic wounds include the use
of various growth factors [6-10], hyperbaric oxygen [11],
and stem cells [7]. Mesenchymal stem cells (MSCs) have
been considered to be suitable for application to ische-
mic wounds [12-14]. Mesenchymal stem cells may be
derived from the bone marrow, umbilical cords or fat.
Adipose-derived stem cells (ASCs) are easily isolated inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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amplify, such that they have more potential for use in
treatment applications than other cell preparations [15].
Extracts of uncultured fat applied to radiation skin ul-
cers and chronic lower extremity ulcers have been repor-
ted in clinical cases, and the wound-healing properties
have been considered to be mediated by stem cells
[16-18]. ASCs are considered to be suitable for the treat-
ment of ischemic wounds because of their potential to
differentiate into several cell types, such as endothelial
cells, and secrete angiogenic and anti-apoptotic factors
[19,20]. ASCs accelerate wound healing in ischemic
models, such as diabetes-impaired wounds or mitomycin
C-treated wounds [21,22]. The local delivery of ASCs via
acellular matrix, such as an atelocollagen matrix, a silk
fibroin-chitosan scaffold or acellular dermal matrix, has
been considered a promising strategy to accelerate
wound healing [22-24].
In this study, we attempted to establish a radiation-
induced wound model and evaluate the effectiveness of
in vitro cultured ASCs for the promotion of the wound
healing of radiation ulcers via angiogenesis.
Methods
Animals
All of the animal experiments were approved and
conducted under the guidance of the Institutional Ani-
mal Care and Use Committee (accredited by the Associ-
ation for Assessment and Accreditation of Laboratory
Animal Care International), National Defense Medical
Center, Taipei, Taiwan.
Isolation and culture of ASCs
Inguinal fat pads were harvested from 9- to 12-week-old
Sprague–Dawley rats (BioLASCO, Taipei, Taiwan). The
isolation and culture of ASCs were followed by our pre-
vious description [24]. The cells were used for experi-
ments at passages 4–6.
Mesenchymal stem cell immunophenotype
Cells from the fourth passage were analyzed for their
immune phenotype. A total of 3 × 105 cells were resus-
pended in 200 μl PBS containing 0.5% bovine serum
albumin and incubated for 30 min at 4°C with mono-
clonal antibodies against rat CD29-fluorescein isothio-
cyanate (FITC) (BD Pharmingen, CA, USA), CD34-FITC
(Santa Cruz Biotechnology, CA, USA), CD45-FITC (BD
Pharmingen), CD90-FITC (BD Pharmingen), CD73
(mouse anti-rat; 5 F/B9, BD Pharmingen), CD31
(ab64543) or vWF (von Willebrand factor) (ab6994)
(Abcam, Cambridge, UK) or the respective isotype con-
trol. For the detection of CD73, goat anti-mouse Alex
Flour 488 (Invitrogen) was used for another round of in-
cubation after PBS washing and resuspension in PBScontaining 0.5% bovine serum albumin (Bio-Rad La-
boratories, CA, USA). The cells were analyzed with a
FACSCalibur cytometer (Becton Dickinson, NJ, USA)
and this procedure has been described previously [24].ASC Differentiation Assays
Putative ASCs were incubated to differentiate into adi-
pocytes and osteoblasts, described previously [24]. For
adipocyte differentiation, cells reaching confluence were
incubated for 7 repetitive cycles of 48 hours in adipogenic
differentiation medium. For osteocyte differentiation, cells
reaching confluence were cultured with osteogenic
medium for 2 weeks. Oil red O (Sigma) and Alizarin red S
(Sigma) dyes were used to identify adipocytes and osteo-
blasts, respectively.Real-time PCR
The total RNA of cultured cells at the indicated pas-
sage number was extracted with Tri Reagent (Ambion,
TX, USA). cDNA was synthesized using Superscript III
reverse transcriptase (Invitrogen, company location
needed). Real-time PCR analysis was performed with a
7500 Real-time PCR system (Applied Biosystems, CA,
USA) using Power SyBr Green PCR master mix (Applied
Biosystems) with the following primers: VEGF sense,
AGGCTGCACCCACGACAGAA; VEGF anti-sense, CT
GGAAGATGTCCACCAGGG; HGF sense, TTTGGCC
ATGAATTTGACCTCT; HGF anti-sense, CTTCTGA
ACACTGAGGAATGTC; GAPDH sense, TCCTGCA
CCACCAACTGC; and GAPDH anti-sense, GCCATC
CACAGTCTTCTG. GAPDH was used as an endogen-
ous reference in each case. The data are presented as the
average of triplicate experiments ± the standard error of
the mean (SEM).ELISA assay
Rat ASCs isolated from three different rats were res-
pectively cultured and expanded in culture medium
(DMEM-10% FBS). At 70-90% confluence, cells were de-
tached and passaged at a ratio of 1:3 at indicated passage
numbers. After 24 hours incubation in culture medium,
cells were switched to DMEM-5% FBS and incubated for
72 hours. Then, the condition medium was collected,
and cell numbers were determined by trypan blue exclu-
sion. The concentrations of vascular endothelial growth
factor (VEGF) and hepatocyte growth factor (HGF) were
measured using sandwich ELISA kit according to the
manufacturer’s instruction: Rat VEGF Immunoassay and
mouse/rat HGF Immunoassay kits were obtained from
R&D Systems (Minneapolis, MN, USA). Data are pre-
sented as pictograms of the secreted factor per 104 cells
at the time of harvest.
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Eight-week-old male rats weighing 250–300 g were used
in this study. After anesthesia with Zoletil 50 (0.1 ml/
100 g) (Virbac, Paris, France) and shaving the wool of
the dorsum, four rats were irradiated with an electron
beam (Primus, Erlangen, Germany) operated at 6 MeV.
The dose rate was 900 cGy/min. A single dose of 50 Gy
was given through an area of 3 cm diameter marked on
the dorsal skin, and the surrounding healthy tissue wasFigure 1 Identification of rat ASCs. (A) The 4th passage of rat ASCs was
CD45, CD73, CD90 and vWF biomarkers. Green lines represent the specific
(B) The 4th passage of rat ASCs was labeled with CM-DiI and observed und
adipogenic and osteogenic differentiation, and the cells were stained withprotected by a 1.2 cm lead shield. The assessment of
acute skin reactions with a visual skin score began ele-
ven days after radiation and was continued every two
days until the 57th day after irradiation. The score was
based on a previously described scoring method [25].
0 = normal;
0.25 = transient erythema, edema, or dry desquamation
on dorsum or sole of the foot;analyzed with flow cytometry for the expression of CD29, CD31, CD34,
fluorescent antibodies, and black lines represent isotype controls.
er a fluorescence microscope. Bar: 50 μm. ASCs were assessed for
Oil red O (C) and Alizarin red S (D), respectively. Scale bar, 200 μm.
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1.0 = epilation in about 50% of exposure area;
1.5 = epilation in >50% of exposure area or some
signs of dry desquamation on the leg; 2.0 = complete
epilation, red foot, or dry desquamation in ≤50% of
exposure area with epilation in ≥50% of exposure
area;
2.5 = complete epilation with definite edema or dry
desquamation in >50% area;
3.0 = moist desquamation in a small area; and
3.5 =moist desquamation in most of the area.
An additional three rats were irradiated with a 50 Gy
electron beam, and the wound tissues were removed at
the first, second and third weeks for histological obser-
vations of the wound model. Normal skin was removed
from a healthy rat as a comparison.
To evaluate the wound size, the ulcerated area of each
rat was recorded with a SANYO Xacti VPC-CA65 digital
camera at weeks 3, 4, 5 and 6 post-radiation. Images
were analyzed with Image-Pro Plus software. Discrimi-
nations between the ulcer and the re-epithelialization of
the skin were performed by two investigators who were
blind to group assignments.Figure 2 Effects of passage number on mRNA expression and secreti
(A-D) Total mRNAs were extracted from three different rat ASCs and revers
levels were analyzed using real-time PCR analysis. Values were normalized
values of P1. Secretion of VEGF (C) and HGF (D) by rat ASCs (n = 3) culture
mean ± SEM. *p < 0.05, **p < 0.01.ASC transplantation and tracking
Three weeks after radiation, the rats were anesthetized,
randomly divided into two groups (n = 8 each group),
and injected with either 1 × 106 ASCs resuspended
in 0.8 ml of PBS (experiment group) or 0.8 ml PBS
(control group) into the wound bed and margin. The
two groups were treated with ASCs (experiment
group) and PBS (control group) for four and five
weeks post-radiation. The experiments ended at week
6 post-radiation, and the skin, including the wounds,
was removed from each rat for histological examin-
ation, immunoblot analysis, vessel density assessment
and dermal thickness measurement. Beside the ani-
mals used for the characterization of wound model
and evaluation of ASCs treatment described previ-
ously, two additional rats were irradiated for tracing
the transplanted ASCs in the ulcerated tissue des-
cribed below.
The fourth-passage ASCs were labeled with 20 μM
fluorescent cell tracker CM-DiI (chloromethyl-benzami-
do derivative of 1,1′-dioctadecyl-3,3,3′3′-tetra- methyl-
inodcarbocyanine) (Molecular Probes, OR, USA) in
accordance with the manufacturer’s recommendations.
The procedure has been described previously [24].on of VEGF and HGF. Passage numbers were shown as P1, P2, etc.
e transcribed into cDNA. The VEGF (A) and HGF (B) mRNA expression
to the level of GAPDH mRNA and expressed relative to normalized
d over 72 hours was measured by ELISA. The data represent the
Figure 3 Wound model of an acute radiation ulcer. The animal
model of radiation ulcers and the experimental design are described
in the Materials and Methods. (A) The skin scores of rats were
evaluated after 50 Gy electron irradiation (n = 4). (B-E) Histological
examination was performed by hematoxylin and eosin staining of
the skin reaction. The histology of skin exposed to 50 Gy irradiation
after 0 days (normal skin) (B), 7 days (C), 14 days (D) and 21 days (E)
is shown. Arrow: vascular dilation and thrombosis. Bar: 200 μm.
Figure 4 ASCs promoted the wound healing of skin with
radiation ulcers. Radiation ulcers were induced and then treated
with the indicated ASCs. (A) Representative images of wounds are
shown at weeks 0, 1, 2 and 3 from eight rats in each group. (B) The
wound size of the control (PBS treated; black bar) and ASC-treated
(white bar) rats was measured. The data represent the mean ± SEM
of eight rats. *p < 0.05; **p < 0.01.
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The removed skin, including the ulcers and re-epithe-
lialized tissue, was fixed in 10% formalin for at least
24 h, embedded in paraffin, and sectioned in 5 μm incre-
ments. Frozen sections were prepared for the immuno-
staining of CD31 (ab64543) or vWF (ab6994) (Abcam,
Cambridge, UK). For the staining of vWF, the tissues
were fixed with 4% paraformaldehyde and permeabilized
with 0.1% Triton X-100. For the staining of CD31, the
tissues were fixed with 4% paraformaldehyde. Morpho-
logical observations were described previously [24].
Immunoblot analysis
Skin samples were homogenized in lysis buffer (100 mM
Tris–HCl, pH 8.0, 150 mM NaCl, 0.1% SDS, and 1%
Triton 100) at 4°C. The cell extracts were separated
through sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis, transferred onto a polyvinylidene difluoride
membrane (Millipore, MA, USA) and detected usingantibodies against CD31 (TLD-3A12, BD Pharmingen)
and Hu Antigen R (HuR) (3A2; Santa Cruz Biotechnology)
as a control.
Vessel density assessment
Three weeks after starting the treatment, wound tissues
of ASC-treated or control group were removed and
made into 8 μm frozen sections. After the staining of
CD31 and DAPI, the blood vessel density of each wound
was calculated and described as follows: for each wound
(n = 8), five non-consecutive tissue sections were made.
For each section, three randomly selected fields (400×
magnification) of ulcer tissues were photographed by
fluorescence microscopy (Leica, Wetzlar, Germany). A
total of 15 images were taken for each wound, and neo-
vasculation was assessed by measuring the CD31 stained
capillaries.
Dermal thickness measurement
Dermal thickness was measured in eight animals from
each group and normal skin as the control. A represen-
tative image of H&E-stained sections was obtained. The
dermal thickness was measured at three points in each
image.
Statistical analysis
All of the data were calculated as the mean ± SEM.
Statistical analyses were performed using a two-tailed
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p < 0.05.
Results
Characterization of rat ASCs
First, we characterized specific cell surface markers of
our isolated cells with flow cytometry analysis. Our
fourth generation of isolated cells was positive for CD29,
CD73 and CD90 but little evidence of hematopoietic
lineage markers CD34 and CD45 and endothelial cell
markers CD31 and vWF, (Figure 1A), consistent with
the characterization of ASCs. The growth of our cul-
tured ASCs was similar to that of the fibroblast-like
phenotype (Figure 1B). ASCs were labeled with the cell
tracker CM-DiI for the cell-tracking experiment de-
scribed later. In addition, our cultured ASCs had the
ability to differentiate into adipocytes and osteocytes,
which were verified with Oil-Red O and Alizarin Red S
staining, respectively (Figure 1C and D). These results
suggested that our isolated cells had characteristics con-
sistent with MSCs [19]. We further examined the
mRNAs, and secretory proteins of VEGF and HGF, two
well-known angiogenic factors, in different rat sources
used for isolating ASCs (Figure 2). Mostly constantFigure 5 Analysis of angiogenesis and blood vessel density in ASC-tre
wound edge were subjected to histological examination. Compared with t
increased in the ASC-treated group (B). Arrows indicate vessel formation and
M: muscle layer; U: ulcer. Bar: 500 μm. (C) Tissue lysates from re-epithelialized
immunoblot analysis against CD31 and HuR (a loading control). (D-F) Three w
into 8 μm frozen sections. Slides were stained with CD31 (green) and DAPI, a
control (D) and ASC (E) group are shown. (F) The blood vessel density was ev
mean ± SEM of eight rats. *p < 0.01.expressions of VEGF and HGF mRNAs in real-time PCR
analysis and secretory proteins in ELISA analysis were
observed at every passage considered, and significant
changes were found at the 4th passage of both factors
(Figure 2), suggesting, at least in part, secretory factors
might play the functional roles for the ASC effect.
Hence, we used 4th passage of ASCs for further experi-
ments in this study.
The establishment of a wound model of acute radiation
skin ulcers
Male Sprague–Dawley rats were exposed to the indi-
cated radiation on the dorsal skin. We assessed radiation
injuries with skin scores (from 0 to 3.5, detailed score in-
formation shown in the Method section) every two days
from 11 to 57 days after exposure, and the average score
was 2.63 ± 0.08 (Figure 3A, dashed line). Peeling in the
radiated areas was observed approximately two weeks
after radiation exposure. The most serious skin damage,
moist ulcers in the exposed areas, was observed four
weeks after radiation. The festering wounds had still not
fully re-epithelialized at the eighth week after exposure.
The ulcerated areas achieved their maximum size at ap-
proximately the third week (data not shown), and thisated tissue. (A-C) After three weeks of treatment, the tissues of the
he control group (A), the capillary density in the dermis was clearly
proliferation sites containing erythrocytes in each wound. E: epidermis;
skin tissue of control and ASC-treated groups were analyzed with
eeks after ASC treatment, ulcerated tissues were removed and processed
fluorescent nuclear stain (blue). Bar: 50 μm. Representative images of the
aluated in the control and ASC-treated groups. The data represent the
Figure 6 Histological assessment demonstrated that ASCs
significantly improved the granulation rate. (A) The dermis of
normal skin served as a comparison. After three weeks of ASC
treatment, the healed skin of each group was assessed. The images
are representative of the control (B) and ASC-treated (C) groups. Bar:
200 μm. (D) The thickness of the dermis was evaluated. The data
represent the mean ± SEM of eight rats. *p < 0.05; **p < 0.001.
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ment in subsequent experiments.
Histological observation showed the characteristics of
radiation ulcers on skin. The dermis of normal skin on
the control rats contained hair follicles (Figure 3B). One
week (score = 0) after irradiation, vascular dilution and
thrombosis were clearly observed (Figure 3C, indicated
as arrows), although the epidermis had not yet fallen off.
Day14 (score around 2.5) and day 21 (score around 3)
after irradiation, fibrosis and a lack of epithelium and
follicles in the tissue were observed (Figure 3D and E) as
previously described [3]. More importantly, the weight
of all of the rats continued to increase after radiation
(data not shown), suggesting that radiation injury did
not cause life-threatening stress to the rats. Therefore,
we had established a model of acute skin radiation
injury.
Transplantation of ASCs could enhance wound healing
ASCs were used to treat skin wound areas of approxi-
mately 3.5 cm2 three weeks after irradiation (Figure 4A
or 4B were not labeled). To allow for even distribution
within the wounds, ASCs were equally divided and
injected into 12 locations in the wound bed and edge.
The wound sizes in the ASC-treated and control groups
were recorded every week. Our quantitative data were
significantly different at the second and third weeks after
starting treatment (week 2, * p < 0.05; week 3, ** p < 0.01)
(Figure 4B), indicating the ASC treatment enhanced the
healing of radiation ulcers.
Transplantation of ASCs increased angiogenesis and
granulation in wound healing
After the third week of ASC treatment, tissues from the
wound edge and healing region were examined with his-
tological examination and immunoblot analysis (Figure 5).
Tissue from the wound edge (labeled as U) showed
growth of the epithelium (labeled as E) and muscle
(labeled as M) toward the ulcer region, and tissue be-
tween the epithelial and muscle layers showed dermal
fibrosis with a lack of hair follicles (Figure 5A and B).
The capillary density in the dermis was clearly in-
creased in the ASC-treated group compared with the
control group (Figure 5A and B, indicated by arrows).
The re-epithelialization of healing skin was identified
by a lack of hair. In the healing regions, the average
CD31 (a vascular endothelial cell marker) expression
of the ASC-treated group was significantly higher than the
control group with immunoblot analysis (Figure 5C).
ASCs also significantly increased blood vessel density
(Figure 5D-E) and the dermal thickness of the healed skin
(Figure 6A-C) in ulcerated tissues. Our results suggested
that ASCs significantly increased the dermal thickness
compared with control, but the thickness was significantlow than normal skin (Figure 6D). Taken together, these
results indicate that the treatment with ASCs could in-
crease the blood supply and the granulation rate in wound
healing compared to control condition.
Tracking of CM-DiI-labeled ASCs after transplantation
To identify the survival, distribution and differentiation
characteristics of ASCs after transplantation, we injected
CM-DiI-labeled ASCs into the ulcerated tissue and ana-
lyzed the preparations two weeks later. In frozen sec-
tions, CM-DiI-labeled cells were clearly distinguished
in the ulcerated tissue; these cells clustered at the site
of the injection but did not disperse into the tissue
(Figure 7A–C). The nuclei of CM-DiI-labeled cells were
labeled with DAPI, and parts of these nuclei colocalized
with the cell proliferation marker Ki67, implying that al-
lografts of ASCs could allow for the survival and prolif-
eration of the tissue of the radiation ulcer (data not
shown). In addition, a portion of CM-DiI-labeled cells
colocalized with the vascular endothelial cell markers
Figure 7 Engrafted CM-DiI-labeled ASCs were expressed within the endothelial cells. (A-C) Images obtained from 16 μm sections frozen
14 days after the injection of CM-DiI-labeled ASCs (red fluorescence) into tissue with radiation ulcers. Phase contrast (A), red fluorescence (B) and
overlay images (C). Bar: 200 μm. (D-K) Confocal images were acquired from 8 μm sections frozen 14 days after the injection of CM-DiI-labeled
ASCs and immunostained with vWF (D-G) or CD31 (H-K). Differential interference contrast image (D and H). Red staining indicates CM-DiI-labeled
ASCs (E and I). Green staining indicates vWF (F) and CD31 (J). Overlay image (G and K).
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a dendritic vascular structure, indicating that ASCs can
contribute to newly formed vasculature in the ulcerated
tissue. The punctate staining of vWF in Figure 7F suggests
that the vWF stored in Weibel-Palade bodies of endothe-
lial cells is consistent with literature descriptions [26,27].
Discussion
As an adjuvant therapy for cancer, Siemens Primus
produces electron or photon radiation for use on the
surface layer of the skin or for deep tissue damage, re-
spectively. In this study, we used electron beam radiation
to simulate skin damage during cancer treatment. Ap-
proximately one week later, the skin began to deteriorate
in appearance; the wound gradually showed edema and
epilation and eventually showed moist desquamation in
the exposure area (Figure 3, days 14–21). These histo-
logical observations are consistent with the characte-
ristics of radiation ulcers. Therefore, we did develop a
modified rat model of acute radiation skin damage for
chronic wounds in this study. In contrast with previous
models (combined radiation–wound or leg ulcers caused
by radiation) [28,29], our model more closely simulates
the chronic wounds caused by clinical radiation ulcersand can provide more adequate tissue for observation
and biochemical analysis.
Isolated ASCs may contain several cell types, including
endothelial cells, smooth muscle cells, pericytes, fib-
roblasts, and preadipocytes [30]. With the increase in
passage numbers, cells gradually present a more homo-
geneous cell population [31]. Although ASCs can differ-
entiate into various cell types, such as adipocytes and
osteocytes in this study, these capabilities may vary with
the cell culture environment and passage number. For
example, studies have shown that ASCs can differentiate
into myocardial cells in primary cell culture but not in
later generations of cells [32]. To achieve the best appli-
cations for different purposes, culture conditions, pas-
sage number and other factors that may affect cell ability
are worthy of more detailed study in the future. In this
study, the results of real-time PCR and ELISA analysis
indicated that the mRNA and secretory protein expres-
sions of VEGF and HGF in ASCs showed an increasing
trend with increasing passage number. The expression
level reached a peak at approximately the 4th-6th gener-
ations of ASCs. Therefore, we chose the 4th generation
of ASCs for subsequent experiments. It is a puzzle to
demonstrate paracrine effects and/or direct ASC effects,
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[20,21].
Clinical cases of the application of processed lipo-
aspirate (PLA) cells in radiation ulcer treatment indicate
that isolated ASCs within PLA cells may play a key role in
wound healing [18]. We further demonstrated that the
allogeneic transplantation of in vitro cultured ASCs
enhanced the healing of radiation ulcers. The results of
cell-tracking experiments, histological examination, and
immunoblot analysis indicate that ASCs could increase
the blood supply and granulation rate in wound healing.
In addition, cell-tracking experiments also showed that
ASCs could survive (14 days) and proliferate in the ulcers
(data not shown), suggesting that these cells create long-
term effects in ulcers. Consistent with previous studies,
our results indicate that transplanted ASCs colocalized
with endothelial markers [24,33]. However, these data are
not enough to conclude that ASCs differentiated into
endothelial cells because the colocalization of these signals
may be due to cell fusion between transplanted ASCs and
endothelial cells of the host. To address this question, het-
erograft experiments combined with species-specific anti-
body examination should be carried out in the future.
Strategies for treating chronic wounds include various
growth factors [6-10], hyperbaric oxygen [11], and stem
cells [8,10]. MSCs have been considered suitable for ap-
plication to ischemic wounds [12-14]. MSCs may come
from bone marrow, umbilical cords or fat. ASCs are eas-
ily isolated in large quantities, being easy to culture and
amplify, and therefore have more potential for treatment
applications [15]. Extracts of uncultured fat applied to
radiation skin ulcers and chronic lower-extremity ulcers
have been reported in clinical cases, and it is considered
that the wound-healing properties come from stem cells
[16-18]. ASCs are considered suitable for the treatment
of ischemic wounds because of their potential for secre-
tion of angiogenic and anti-apoptotic factors, and differen-
tiation into several cell types such as endothelial cells
[19,20]. ASCs accelerate wound healing in ischemic
models such as diabetes-impaired wounds or mitomycin
C-treated wounds have been reported [21,22]. Local deliv-
ery of ASCs via acellular matrix such as silk fibroin-
chitosan scaffold, atelocollagen matrixwas or acellular
dermal matrix has been considered a promising strategy
to accelerated wound healing [22-24]. Previous studies
have shown that bone marrow-derived MSCs that express
human platelet-derived growth factor A and human beta-
defensin 2 promote wound healing [28], and such a strat-
egy may apply to our ASC treatment of radiation ulcers.
In the future, more effort will be required to improve
the use of ASCs in the treatment of radiation injuries. In
this study, we injected ASCs into the site of the radiation
wound. However, cells injected into the wound bed did
not spread evenly but clustered at the location of theinjection. To overcome this obstacle, ASC therapy
through ASC-seeded scaffolds [15,34] or monolayer
stem cells [32] may be applied. In future clinical applica-
tions, patients with local radiation injuries may use
ASCs from non-irradiated sites and those with systemic
radiation injuries may use ASCs or adipose tissue from
‘stockpiles’ or ‘banks’ for treatment [35].
Conclusions
We established a rat model of acute radiation ulcers
and demonstrated that the allograft transplantation of
in vitro cultured ASCs improved the wound healing of
radiation ulcers. The histological examination of the
wound edge and the immunoblot analysis of the re-
epithelialization region both indicated that ASCs
contributed directly to vascularization by acting as
angiogenesis-promoting cells and/or likely by differen-
tiating into endothelial cells. In the future, a better
understanding of the impact of ASCs on ulcers and
improvements in the technology of ASC treatment
and storage will contribute to more effective ASC therapy
for radiation ulcers and other chronic wounds.
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